Skip to main content
. 2020 Feb 24;4(1):e100013. doi: 10.1136/bmjos-2019-100013

Figure 2.

Figure 2

Inclusion of advanced age or a comorbidity in preclinical stroke studies testing an intervention. Presented as a percentage of all studies (n=842): n=746 non-comorbid (88.6%), n=68 hypertension (8.1%), n=14 diabetic/hyperglycaemic (1.7%), n=12 aged (1.4%), n=2 infection (0.2%).